The genetic association of DUSP6 with bipolar disorder and its effect on ERK activity

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 37, Issue 1, 2012, Pages 41-49

  Kim, Se Hyun ^a   Shin, Soon Young ^b   Lee, Kyu Young ^c   Joo, Eun Jeong ^c   Song, Joo Youn ^a,d   Ahn, Yong Min ^a,d   Lee, Young Han ^b   Kim, Yong Sik ^a,d  

^a Seoul National University Hospital   (South Korea)

^b Konkuk University   (South Korea)

^c Eulji General Hospital   (South Korea)

^d Seoul National University College of Medicine   (South Korea)

Author keywords

Bipolar disorder; Dual specificity phosphatase 6; Genetic association; Leu114Val polymorphism; Ser144Ala polymorphism

Indexed keywords

ALANINE; LEUCINE; LITHIUM CHLORIDE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; SERINE; VALINE;

ADULT; ARTICLE; BIPOLAR DISORDER; CONTROLLED STUDY; DRUG RESPONSE; DUSP6 GENE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; FEMALE; GENE; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; HAPLOTYPE; HUMAN; HUMAN CELL; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; PATHOGENESIS; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; SOUTH KOREA;

ADULT; ALLELES; BIPOLAR DISORDER; DUAL SPECIFICITY PHOSPHATASE 6; ENZYME ACTIVATION; FEMALE; GENETIC ASSOCIATION STUDIES; HELA CELLS; HUMANS; MALE; MAP KINASE SIGNALING SYSTEM; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; YOUNG ADULT;

EID: 84857786209     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2011.11.014     Document Type: Article

References (89)

1. Akil H., Evans S.J., Turner C.A., Perez J., Myers R.M., Bunney W.E., et al. The fibroblast growth factor family and mood disorders. Novartis Foundation Symposium 2008, 289:94-96. discussion 7-100, 93-5.
2. Aragon F., Pujades C. FGF signaling controls caudal hindbrain specification through Ras-ERK1/2 pathway. BMC Developmental Biology 2009, 9:61.
3. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265.
4. Bhalla U.S., Ram P.T., Iyengar R. MAP kinase phosphatase as a locus of flexibility in a mitogen-activated protein kinase signaling network. Science 2002, 297:1018-1023.
5. Biedler J.L., Helson L., Spengler B.A. Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Research 1973, 33:2643-2652.
6. Braunig P., Sarkar R., Effenberger S., Schoofs N., Kruger S. Gender differences in psychotic bipolar mania. Gender Medicine 2009, 6:356-361.
7. Burt V.K., Rasgon N. Special considerations in treating bipolar disorder in women. Bipolar Disorders 2004, 6:2-13.
8. Camps M., Nichols A., Arkinstall S. Dual specificity phosphatases: a gene family for control of MAP kinase function. The FASEB Journal 2000, 14:6-16.
9. Camps M., Nichols A., Gillieron C., Antonsson B., Muda M., Chabert C., et al. Catalytic activation of the phosphatase MKP-3 by ERK2 mitogen-activated protein kinase. Science 1998, 280:1262-1265.
10. Carter C.J. Multiple genes and factors associated with bipolar disorder converge on growth factor and stress activated kinase pathways controlling translation initiation: implications for oligodendrocyte viability. Neurochemistry International 2007, 50:461-490.
11. Chen G., Manji H.K. The extracellular signal-regulated kinase pathway: an emerging promising target for mood stabilizers. Current Opinion in Psychiatry 2006, 19:313-323.
12. Cui Y., Parra I., Zhang M., Hilsenbeck S.G., Tsimelzon A., Furukawa T., et al. Elevated expression of mitogen-activated protein kinase phosphatase 3 in breast tumors: a mechanism of tamoxifen resistance. Cancer Research 2006, 66:5950-5959.
13. Curtis D., Kalsi G., Brynjolfsson J., McInnis M., O'Neill J., Smyth C., et al. Genome scan of pedigrees multiply affected with bipolar disorder provides further support for the presence of a susceptibility locus on chromosome 12q23-q24, and suggests the presence of additional loci on 1p and 1q. Psychiatric Genetics 2003, 13:77-84.
14. Dawson E., Parfitt E., Roberts Q., Daniels J., Lim L., Sham P., et al. Linkage studies of bipolar disorder in the region of the Darier's disease gene on chromosome 12q23-24.1. American Journal of Medical Genetics 1995, 60:94-102.
15. de Bakker P.I., Yelensky R., Pe'er I., Gabriel S.B., Daly M.J., Altshuler D. Efficiency and power in genetic association studies. Nature Genetics 2005, 37:1217-1223.
16. Di Daniel E., Mudge A.W., Maycox P.R. Comparative analysis of the effects of four mood stabilizers in SH-SY5Y cells and in primary neurons. Bipolar Disorders 2005, 7:33-41.
17. Dickinson R.J., Eblaghie M.C., Keyse S.M., Morriss-Kay G.M. Expression of the ERK-specific MAP kinase phosphatase PYST1/MKP3 in mouse embryos during morphogenesis and early organogenesis. Mechanisms of Development 2002, 113:193-196.
18. Dong E., Chen Y., Gavin D.P., Grayson D.R., Guidotti A. Valproate induces DNA demethylation in nuclear extracts from adult mouse brain. Epigenetics 2010, 5.
19. Dong E., Nelson M., Grayson D.R., Costa E., Guidotti A. Clozapine and sulpiride but not haloperidol or olanzapine activate brain DNA demethylation. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:13614-13619.
20. Dudbridge F. Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data. Human Heredity 2008, 66:87-98.
21. Duman C.H., Schlesinger L., Kodama M., Russell D.S., Duman R.S. A role for MAP kinase signaling in behavioral models of depression and antidepressant treatment. Biological Psychiatry 2007, 61:661-670.
22. Eblaghie M.C., Song S.J., Kim J.Y., Akita K., Tickle C., Jung H.S. Interactions between FGF and Wnt signals and Tbx3 gene expression in mammary gland initiation in mouse embryos. Journal of Anatomy 2004, 205:1-13.
23. Echevarria D., Martinez S., Marques S., Lucas-Teixeira V., Belo J.A. Mkp3 is a negative feedback modulator of Fgf8 signaling in the mammalian isthmic organizer. Developmental Biology 2005, 277:114-128.
24. Einat H., Yuan P., Gould T.D., Li J., Du J., Zhang L., et al. The role of the extracellular signal-regulated kinase signaling pathway in mood modulation. Journal of Neuroscience 2003, 23:7311-7316.
25. Frye M.A., Altshuler L.L., McElroy S.L., Suppes T., Keck P.E., Denicoff K., et al. Gender differences in prevalence, risk, and clinical correlates of alcoholism comorbidity in bipolar disorder. The American Journal of Psychiatry 2003, 160:883-889.
26. Ghribi O., Prammonjago P., Herman M.M., Spaulding N.K., Savory J. Abeta(1-42)-induced JNK and ERK activation in rabbit hippocampus is differentially regulated by lithium but is not involved in the phosphorylation of tau. Brain Research. Molecular Brain Research 2003, 119:201-206.
27. Goes F.S., Willour V.L., Zandi P.P., Belmonte P.L., MacKinnon D.F., Mondimore F.M., et al. Sex-specific association of the Reelin gene with bipolar disorder. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics 2010, 153B:549-553.
28. Gogos A., van den Buuse M., Rossell S. Gender differences in prepulse inhibition (PPI) in bipolar disorder: men have reduced PPI, women have increased PPI. The International Journal of Neuropsychopharmacology 2009, 12:1249-1259.
29. Goldbeter A., Pourquie O. Modeling the segmentation clock as a network of coupled oscillations in the Notch, Wnt and FGF signaling pathways. Journal of Theoretical Biology 2008, 252:574-585.
30. Groom L.A., Sneddon A.A., Alessi D.R., Dowd S., Keyse S.M. Differential regulation of the MAP, SAP and RK/p38 kinases by Pyst1, a novel cytosolic dual-specificity phosphatase. EMBO Journal 1996, 15:3621-3632.
31. Hao Y., Creson T., Zhang L., Li P., Du F., Yuan P., et al. Mood stabilizer valproate promotes ERK pathway-dependent cortical neuronal growth and neurogenesis. Journal of Neuroscience 2004, 24:6590-6599.
32. Higgs B.W., Elashoff M., Richman S., Barci B. An online database for brain disease research. BMC Genomics 2006, 7:70.
33. Jeffrey K.L., Camps M., Rommel C., Mackay C.R. Targeting dual-specificity phosphatases: manipulating MAP kinase signalling and immune responses. Nature Reviews. Drug Discovery 2007, 6:391-403.
34. Jones I., Jacobsen N., Green E.K., Elvidge G.P., Owen M.J., Craddock N. Evidence for familial cosegregation of major affective disorder and genetic markers flanking the gene for Darier's disease. Molecular Psychiatry 2002, 7:424-427.
35. Joo E.J., Joo Y.H., Hong J.P., Hwang S., Maeng S.J., Han J.H., et al. Korean version of the diagnostic interview for genetic studies: validity and reliability. Comprehensive Psychiatry 2004, 45:225-229.
36. Karlsson M., Mathers J., Dickinson R.J., Mandl M., Keyse S.M. Both nuclear-cytoplasmic shuttling of the dual specificity phosphatase MKP-3 and its ability to anchor MAP kinase in the cytoplasm are mediated by a conserved nuclear export signal. Journal of Biological Chemistry 2004, 279:41882-41891.
37. Kawakami Y., Rodriguez-Leon J., Koth C.M., Buscher D., Itoh T., Raya A., et al. MKP3 mediates the cellular response to FGF8 signalling in the vertebrate limb. Nature Cell Biology 2003, 5:513-519.
38. Kennedy N., Boydell J., Kalidindi S., Fearon P., Jones P.B., van Os J., et al. Gender differences in incidence and age at onset of mania and bipolar disorder over a 35-year period in Camberwell, England. The American Journal of Psychiatry 2005, 162:257-262.
39. Kim J.J., Verdu P., Pakstis A.J., Speed W.C., Kidd J.R., Kidd K.K. Use of autosomal loci for clustering individuals and populations of East Asian origin. Human Genetics 2005, 117:511-519.
40. Kim S.H., Seo M.S., Jeon W.J., Yu H.S., Park H.G., Jung G.A., et al. Haloperidol regulates the phosphorylation level of the MEK-ERK-p90RSK signal pathway via protein phosphatase 2A in the rat frontal cortex. The International Journal of Neuropsychopharmacology 2008, 11:509-517.
41. Kim S.H., Yu H.S., Park H.G., Jeon W.J., Song J.Y., Kang U.G., et al. Dose-dependent effect of intracerebroventricular injection of ouabain on the phosphorylation of the MEK1/2-ERK1/2-p90RSK pathway in the rat brain related to locomotor activity. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2008, 32:1637-1642.
42. Klock A., Herrmann B.G. Cloning and expression of the mouse dual-specificity mitogen-activated protein (MAP) kinase phosphatase Mkp3 during mouse embryogenesis. Mechanisms of Development 2002, 116:243-247.
43. Kuo P.H., Neale M.C., Riley B.P., Patterson D.G., Walsh D., Prescott C.A., et al. A genome-wide linkage analysis for the personality trait neuroticism in the Irish affected sib-pair study of alcohol dependence. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics 2007, 144B:463-468.
44. Kuratomi G., Iwamoto K., Bundo M., Kusumi I., Kato N., Iwata N., et al. Aberrant DNA methylation associated with bipolar disorder identified from discordant monozygotic twins. Molecular Psychiatry 2008, 13:429-441.
45. Lee K.Y., Ahn Y.M., Joo E.J., Chang J.S., Kim Y.S. The association of DUSP6 gene with schizophrenia and bipolar disorder: its possible role in the development of bipolar disorder. Molecular Psychiatry 2006, 11:425-426.
46. Li C., Scott D.A., Hatch E., Tian X., Mansour S.L. Dusp6 (Mkp3) is a negative feedback regulator of FGF-stimulated ERK signaling during mouse development. Development 2007, 134:167-176.
47. Liu B. Association of the dusp6 (mkp3) gene with mouse brain weight and forebrain structure. Journal of Child Neurology 2008, 23:624-627.
48. Mai L., Jope R.S., Li X. BDNF-mediated signal transduction is modulated by GSK3beta and mood stabilizing agents. Journal of Neurochemistry 2002, 82:75-83.
49. Maillet M., Purcell N.H., Sargent M.A., York A.J., Bueno O.F., Molkentin J.D. DUSP6 (MKP3) null mice show enhanced ERK1/2 phosphorylation at baseline and increased myocyte proliferation in the heart affecting disease susceptibility. Journal of Biological Chemistry 2008, 283:31246-31255.
50. Matigian N., Windus L., Smith H., Filippich C., Pantelis C., McGrath J., et al. Expression profiling in monozygotic twins discordant for bipolar disorder reveals dysregulation of the WNT signalling pathway. Molecular Psychiatry 2007, 12:815-825.
51. McMahon F.J., Stine O.C., Meyers D.A., Simpson S.G., DePaulo J.R. Patterns of maternal transmission in bipolar affective disorder. American Journal of Human Genetics 1995, 56:1277-1286.
52. Mill J., Tang T., Kaminsky Z., Khare T., Yazdanpanah S., Bouchard L., et al. Epigenomic profiling reveals DNA-methylation changes associated with major psychosis. American Journal of Human Genetics 2008, 82:696-711.
53. Molina G., Vogt A., Bakan A., Dai W., Queiroz de Oliveira P., Znosko W., et al. Zebrafish chemical screening reveals an inhibitor of Dusp6 that expands cardiac cell lineages. Nature Chemical Biology 2009, 5:680-687.
54. Morissette J., Villeneuve A., Bordeleau L., Rochette D., Laberge C., Gagne B., et al. Genome-wide search for linkage of bipolar affective disorders in a very large pedigree derived from a homogeneous population in Quebec points to a locus of major effect on chromosome 12q23-q24. American Journal of Medical Genetics 1999, 88:567-587.
55. Moser D., Ekawardhani S., Kumsta R., Palmason H., Bock C., Athanassiadou Z., et al. Functional analysis of a potassium-chloride co-transporter 3 (SLC12A6) promoter polymorphism leading to an additional DNA methylation site. Neuropsychopharmacology 2009, 34:458-467.
56. Muda M., Theodosiou A., Rodrigues N., Boschert U., Camps M., Gillieron C., et al. The dual specificity phosphatases M3/6 and MKP-3 are highly selective for inactivation of distinct mitogen-activated protein kinases. Journal of Biological Chemistry 1996, 271:27205-27208.
57. Okamoto H., Voleti B., Banasr M., Sarhan M., Duric V., Girgenti M.J., et al. Wnt2 expression and signaling is increased by different classes of antidepressant treatments. Biological Psychiatry 2010, 68:521-527.
58. Owens D.M., Keyse S.M. Differential regulation of MAP kinase signalling by dual-specificity protein phosphatases. Oncogene 2007, 26:3203-3213.
59. Patsopoulos N.A., Tatsioni A., Ioannidis J.P. Claims of sex differences: an empirical assessment in genetic associations. JAMA : The Journal of the American Medical Association 2007, 298:880-893.
60. Pozzi L., Hakansson K., Usiello A., Borgkvist A., Lindskog M., Greengard P., et al. Opposite regulation by typical and atypical anti-psychotics of ERK1/2, CREB and Elk-1 phosphorylation in mouse dorsal striatum. Journal of Neurochemistry 2003, 86:451-459.
61. Preisig M., Bellivier F., Fenton B.T., Baud P., Berney A., Courtet P., et al. Association between bipolar disorder and monoamine oxidase A gene polymorphisms: results of a multicenter study. The American Journal of Psychiatry 2000, 157:948-955.
62. Reth M. Hydrogen peroxide as second messenger in lymphocyte activation. Nature Immunology 2002, 3:1129-1134.
63. Riva M.A., Molteni R., Bedogni F., Racagni G., Fumagalli F. Emerging role of the FGF system in psychiatric disorders. Trends in Pharmacological Sciences 2005, 26:228-231.
64. Rosa A., Picchioni M.M., Kalidindi S., Loat C.S., Knight J., Toulopoulou T., et al. Differential methylation of the X-chromosome is a possible source of discordance for bipolar disorder female monozygotic twins. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics 2008, 147B:459-462.
65. Shifman S., Bronstein M., Sternfeld M., Pisante A., Weizman A., Reznik I., et al. COMT: a common susceptibility gene in bipolar disorder and schizophrenia. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics 2004, 128B:61-64.
66. Sibisi C.D. Sex differences in the age of onset of bipolar affective illness. The British Journal of Psychiatry 1990, 156:842-845.
67. Smith A., Price C., Cullen M., Muda M., King A., Ozanne B., et al. Chromosomal localization of three human dual specificity phosphatase genes (DUSP4, DUSP6, and DUSP7). Genomics 1997, 42:524-527.
68. Smith T.G., Sweetman D., Patterson M., Keyse S.M., Munsterberg A. Feedback interactions between MKP3 and ERK MAP kinase control scleraxis expression and the specification of rib progenitors in the developing chick somite. Development 2005, 132:1305-1314.
69. Struyf J., Dobrin S., Page D. Combining gene expression, demographic and clinical data in modeling disease: a case study of bipolar disorder and schizophrenia. BMC Genomics 2008, 9:531.
70. Suppes T., Mintz J., McElroy S.L., Altshuler L.L., Kupka R.W., Frye M.A., et al. Mixed hypomania in 908 patients with bipolar disorder evaluated prospectively in the Stanley Foundation Bipolar Treatment Network: a sex-specific phenomenon. Archives of General Psychiatry 2005, 62:1089-1096.
71. Tabangin M.E., Woo J.G., Martin L.J. The effect of minor allele frequency on the likelihood of obtaining false positives. BMC Proceedings 2009, 3(Suppl 7):S41.
72. Tamura Y., Kunugi H., Ohashi J., Hohjoh H. Epigenetic aberration of the human REELIN gene in psychiatric disorders. Molecular Psychiatry 2007, 12(519):93-600.
73. Theodosiou A., Ashworth A. MAP kinase phosphatases. Genome Biology 2002, 3. REVIEWS3009.
74. Thomson P.A., Wray N.R., Millar J.K., Evans K.L., Hellard S.L., Condie A., et al. Association between the TRAX/DISC locus and both bipolar disorder and schizophrenia in the Scottish population. Molecular Psychiatry 2005, 10:657-668. 16.
75. Thomson P.A., Wray N.R., Thomson A.M., Dunbar D.R., Grassie M.A., Condie A., et al. Sex-specific association between bipolar affective disorder in women and GPR50, an X-linked orphan G protein-coupled receptor. Molecular Psychiatry 2005, 10:470-478.
76. Tian C., Kosoy R., Lee A., Ransom M., Belmont J.W., Gregersen P.K., et al. Analysis of East Asia genetic substructure using genome-wide SNP arrays. PLoS One 2008, 3:e3862.
77. Toyota T., Watanabe A., Shibuya H., Nankai M., Hattori E., Yamada K., et al. Association study on the DUSP6 gene, an affective disorder candidate gene on 12q23, performed by using fluorescence resonance energy transfer-based melting curve analysis on the LightCycler. Molecular Psychiatry 2000, 5:489-494.
78. Tremolizzo L., Doueiri M.S., Dong E., Grayson D.R., Davis J., Pinna G., et al. Valproate corrects the schizophrenia-like epigenetic behavioral modifications induced by methionine in mice. Biological Psychiatry 2005, 57:500-509.
79. Turner C.A., Akil H., Watson S.J., Evans S.J. The fibroblast growth factor system and mood disorders. Biological Psychiatry 2006, 59:1128-1135.
80. Valjent E., Corvol J.C., Pages C., Besson M.J., Maldonado R., Caboche J. Involvement of the extracellular signal-regulated kinase cascade for cocaine-rewarding properties. Journal of Neuroscience 2000, 20:8701-8709.
81. Valjent E., Pages C., Herve D., Girault J.A., Caboche J. Addictive and non-addictive drugs induce distinct and specific patterns of ERK activation in mouse brain. European Journal of Neuroscience 2004, 19:1826-1836.
82. Valjent E., Pages C., Rogard M., Besson M.J., Maldonado R., Caboche J. Delta 9-tetrahydrocannabinol-induced MAPK/ERK and Elk-1 activation in vivo depends on dopaminergic transmission. European Journal of Neuroscience 2001, 14:342-352.
83. Viguera A.C., Tondo L., Baldessarini R.J. Sex differences in response to lithium treatment. The American Journal of Psychiatry 2000, 157:1509-1511.
84. Wexler E.M., Geschwind D.H., Palmer T.D. Lithium regulates adult hippocampal progenitor development through canonical Wnt pathway activation. Molecular Psychiatry 2008, 13:285-292.
85. Wu J., Pankow J.S., Tracy R.P., North K.E., Myers R.H., Feitosa M.E., et al. A QTL on 12q influencing an inflammation marker and obesity in white women: the NHLBI Family Heart Study. Obesity (Silver Spring) 2009, 17:525-531.
86. Xu S., Furukawa T., Kanai N., Sunamura M., Horii A. Abrogation of DUSP6 by hypermethylation in human pancreatic cancer. Journal of Human Genetics 2005, 50:159-167.
87. Yuan P., Zhou R., Wang Y., Li X., Li J., Chen G., et al. Altered levels of extracellular signal-regulated kinase signaling proteins in postmortem frontal cortex of individuals with mood disorders and schizophrenia. Journal of Affective Disorders 2010, 124:164-169.
88. Yuan P.X., Huang L.D., Jiang Y.M., Gutkind J.S., Manji H.K., Chen G. The mood stabilizer valproic acid activates mitogen-activated protein kinases and promotes neurite growth. Journal of Biological Chemistry 2001, 276:31674-31683.
89. Zandi P.P., Belmonte P.L., Willour V.L., Goes F.S., Badner J.A., Simpson S.G., et al. Association study of Wnt signaling pathway genes in bipolar disorder. Archives of General Psychiatry 2008, 65:785-793.